5月19日,毕得医药发布公告称,经董事长提名,董事会提名委员会资格审核,董事会同意聘任王轩担任董事会秘书职务。履历资料显示,王轩曾就职于中信建投投资银行部,任高级副总裁、保荐代表人、内核委员;2025年2月至今任毕得医药投资者关系总监。中信建投2024年报披露,2024年董监高合计薪酬为2014.68万元,较上年同期的4701.92万元相比缩减超过一半。其中,2024年年薪最高的高管是原董事长王...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.